NatashaPillay SmileyDO

Clinical Trials

• Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery Start of enrollment: 2019 Jul 25

  Suspended

  Phase 1, Phase 2

  Roles: Contact

• A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17

  Recruiting

  Phase 1, Phase 2

  Roles: Contact

• A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma Start of enrollment: 2022 Jul 01

  Recruiting

  Phase 1

  Roles: Contact

• A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01

  Active, not recruiting

  Phase 1

  Roles: Contact

• Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04

  Recruiting

  Not Applicable

  Roles: Contact

• HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma Start of enrollment: 2022 Jul 27

  Recruiting

  Phase 1

  Roles: Contact

• Join now to see all